Gossamer Bio, Inc. (GOSS) intrinsic value & 10-year financials
Gossamer Bio, Inc. (GOSS) has a Graham intrinsic value of $69.22 per share. At $8.77 on Oct 17, 2026, the stock trades 87% below that value. Over the last 10 fiscal years revenue shrank 57.7% a year to $48.5M, with an average return on invested capital of 193.7%.
- Graham intrinsic value
- $69.22
- Share price (Oct 17, 2026)
- $8.77
- Price vs Graham value
- 87% below
- Market cap
- $2.0B
- Revenue (FY2025)
- $48.5M
- Revenue growth (10-yr CAGR)
- -57.7%
- ROIC (10-yr avg)
- 193.7%
- Free cash flow (FY2025)
- -$171.3M
GOSS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $48.5M | -$170.4M | -$0.75 | -$171.3M | -352.2% | 201.7% |
| FY2024 | $114.7M | -$56.5M | -$0.25 | -$3.5M | -52.2% | -386.0% |
| FY2023 | $0 | -$179.8M | -$1.18 | -$159.2M | — | 1240.9% |
| FY2022 | $0 | -$229.4M | -$2.71 | -$187.4M | — | 426.6% |
| FY2021 | — | -$234.0M | -$3.13 | -$190.4M | — | 295.2% |
| FY2020 | — | -$243.4M | -$3.55 | -$177.9M | — | -387.3% |
| FY2019 | — | -$180.3M | -$3.29 | -$147.8M | — | -73.1% |
| FY2018 | — | -$147.0M | — | -$54.5M | — | 234.8% |
| FY2017 | — | -$6.8M | — | — | — | 190.5% |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Gossamer Bio, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Gossamer Bio, Inc. has historically struggled to out-earn its cost of capital, averaging just -6.1% ROIC.
Gossamer Bio, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Gossamer Bio, Inc. is modeled at -57.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $69.22 per share.